Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
W748Wt7UFFqrTuRd